Celosia Therapeutics

Sydney, Australia

A biotechnology company that uses gene therapy to treat neurodegenerative diseases.

$16.8M raised

Nov 2024

Series A

Biopharma Biotechnology

Top Investors

Uniseed

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Celosia Therapeutics

How much funding has Celosia Therapeutics raised?

Celosia Therapeutics has raised $16.8M in total funding. The most recent round was Series A. The last funding was announced in November 2024.

Who are Celosia Therapeutics's investors?

Celosia Therapeutics's investors include Uniseed.

Where is Celosia Therapeutics headquartered?

Celosia Therapeutics is headquartered in Sydney, Australia.

What does Celosia Therapeutics do?

A biotechnology company that uses gene therapy to treat neurodegenerative diseases.

What stage is Celosia Therapeutics at?

Celosia Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 27, 2024.

MLA

"Celosia Therapeutics — Funding & Investors." VCBacked, November 27, 2024, https://www.vcbacked.co/company/celosia-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2024). Celosia Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/celosia-therapeutics

Wikipedia (cite web)

{{cite web |title=Celosia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/celosia-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 27, 2024.